- Home
- Technology
- Products & Services
-
Support
-
News
- mRNA-1647，the first infectious disease mRNA vaccine to enter the second phase of research
- Onpattro, The First FDA-approved RNAi Drug
- FDA approves first RNAi treatment for inherited rare diseases
- Alnylam's third RNAi therapy Lumasiran was approved by the European Union for the treatment of primary hyperoxaluria type 1 (PH1)
- Competing for the last mile of vaccine research and development, mRNA vaccines become a hot spot for competition
- Resources
- FAQs
-
News
- Ordering
- About Us
- Contact Us
- Careers
